News und Analysen
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five
Stock-Split Watch: Could These 2 Growth Stocks Be Next?
Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and
3 Red-Hot Growth Stocks That Are Still Cheap Buys
Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?
Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely
Is BioNTech Stock a Buy Now?
BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q3 2023 Earnings CallOct 24, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Centene (CNC) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q3 2023 Earnings CallOct 24, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
Abbott Laboratories (NYSE: ABT) has been a disappointing investment in recent years. While COVID-19 testing gave the business a boost, this has largely been a slow-growing company. And since 2020
2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years
Many growth stocks have come under pressure this year due to worsening macroeconomic conditions. Investors are concerned about inflation and a slowdown in the economy. Two stocks that have been
The Best Stocks to Invest $5,000 In Right Now
Bear markets and bull markets come and go, so it's best to avoid building your portfolio around one specific market phase. Instead, pick up shares of companies with potential to grow your wealth
3 Unstoppable Stocks to Buy Sooner Rather Than Later
Some stocks have the "it" factor. They've got such tremendous growth prospects that investors want to add them to their portfolios without any hesitation.
Three Motley Fool investors think they've
Pfizer Just Announced Layoffs. Should You Still Buy the Stock?
On October 13, Pfizer (NYSE: PFE) served up a platter of bad news for investors. Aside from lowering its estimates for sales of its jab and its antiviral pill for COVID, the company reported that
3 Safe Dividend Stocks to Beat Inflation
Like it or not, inflation remains higher than Americans have been accustomed to, and the impacts of last year's price surge have not gone away. As of September, inflation as measured by the Consumer
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
Pfizer (NYSE: PFE) and Roche (OTC: RHHBY) have disappointed investors this year. Pfizer's shares have dropped more than 39% this year, and it's trading near its 52-week low. Roche has seen its stock
Is Pfizer a Bad News Buy Right Now?
Pfizer (NYSE: PFE) last year brought in record sales of more than $100 billion thanks to its dominance in the coronavirus prevention and treatment markets. The company sells the top vaccine
3 Under-the-Radar Biotech Stocks to Buy in 2023
Biotech stocks have been beaten down in 2023, with the sector off nearly 4% this year while the S&P 500 is up more than 15%. But some of the larger, better known biotech stocks have thrived --
Is AbbVie Stock Too Pricey to Touch Right Now?
For a company in the midst of a transition away from the medicine that made it a star performer over the last decade, AbbVie's (NYSE: ABBV) valuation looks surprisingly high. Why is the market
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines --
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Abbott Laboratories (NYSE: ABT)Q3 2023 Earnings CallOct 18, 2023, 9:00 a.m. ET
Operator
Source Fool.com
2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value
Diabetes care and aesthetics. Those are two areas of healthcare that should provide investors with ample growth opportunities in the long run. Two companies that are in solid positions to capitalize
3 Struggling Stocks Investors Shouldn't Buy on the Dip
Stocks that are crashing in value can sometimes make for good contrarian investments -- provided that there's a reason to expect a turnaround. But in some situations, investors are better off just
Why Pfizer Stock Slipped Today
Pharmaceutical giant Pfizer (NYSE: PFE) wasn't looking very tall or strong on the stock exchange Tuesday. The company's share price dipped by nearly 2% over the course of the trading session
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
Industries with endless demand are great places to find dividend stocks. Healthcare might be the best example of this. No matter how much technology changes, the need to prevent and treat disease
2 Biotech Stocks That Could Make You Richer
Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products